Datopotamab deruxtecan shows promising anti-tumour activity Presented ByDr Ian Krop, Dana-Farber Cancer Institute, MA, USA TrialPhase 1, TROPION-PanTumor01 ConferenceSABCS 2021 31 January, 2022 18:05